Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging

Telomeres » Institutional Study » Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging

April 28, 2017 | Amy | Leave a comment

Peer-Reviewed Scientific Journal:
Biological Psychiatry

Size of study:
88 subjects, 44 with mood disorders, 44 age matched controls

Summary
Our data show a significant telomere shortening in PBMC from AD versus controls (P=0.04).Telomere length of T cells, correlated with AD disease status, measured by Mini Mental Status Exam (MMSE) scores (P=0.025). T cell telomere length also inversely correlated with serum levels of the proinflammatory cytokine TNFalpha (a clinical marker of disease status), with the proportion of CD8+ T cells lacking expression of the CD28 costimulatory molecule, and with apoptosis. These findings suggest an immune involvement in AD pathogenesis.

Link to study

SEE THE FULL STUDY

Leave a Reply Cancel reply

The TeloYears test is not intended for screening, diagnosing, treating or preventing diseases or medical conditions. The TeloYears genetic test may indicate the possibility of identifying a rare telomere syndrome associated with extremely shorter or longer average telomere length (ATL). In these rare cases, further testing and consultation with a doctor to rule in or rule out a telomere syndrome is recommended. The test is available for individuals between the ages of 20 to 80 within the United States, except for the states of Maryland and New York. The information provided by the TeloYears test should not be used to replace medically appropriate screening tests recommended based upon actual age or other risk factors, nor should the information be used to make decisions about diagnosis or treatment of diseases or medical conditions. The Telomere Diagnostics lab is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by Telomere Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration.